New Zealand markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.8651-0.0595 (-6.43%)
As of 03:16PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.99B
Enterprise value 1.29B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.15
Price/book (mrq)1.81
Enterprise value/revenue 5.12
Enterprise value/EBITDA -1.57

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 3-29.39%
S&P500 52-week change 321.23%
52-week high 32.5450
52-week low 30.8500
50-day moving average 31.2022
200-day moving average 31.5702

Share statistics

Avg vol (3-month) 323.09M
Avg vol (10-day) 328.9M
Shares outstanding 51.65B
Implied shares outstanding 62.15B
Float 81.12B
% held by insiders 16.74%
% held by institutions 183.44%
Shares short (28 Mar 2024) 4270.83M
Short ratio (28 Mar 2024) 411.02
Short % of float (28 Mar 2024) 419.94%
Short % of shares outstanding (28 Mar 2024) 412.58%
Shares short (prior month 29 Feb 2024) 4255.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-515.53%

Management effectiveness

Return on assets (ttm)-21.82%
Return on equity (ttm)-63.02%

Income statement

Revenue (ttm)251.46M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)-64.60%
Gross profit (ttm)N/A
EBITDA -662.28M
Net income avi to common (ttm)-892.87M
Diluted EPS (ttm)-0.4600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)944.07M
Total cash per share (mrq)0.47
Total debt (mrq)241.77M
Total debt/equity (mrq)22.04%
Current ratio (mrq)6.11
Book value per share (mrq)0.55

Cash flow statement

Operating cash flow (ttm)-295.5M
Levered free cash flow (ttm)-116.14M